Suzhou, China

Jinchao Ai

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jinchao Ai: Innovator in Pharmaceutical Chemistry

Introduction

Jinchao Ai is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 5 patents to his name, Ai is recognized for his work in creating solutions for various health-related issues.

Latest Patents

Among his latest patents, Ai has developed isotope-enriched 3-amino-1-propanesulfonic acid derivatives and their uses. These compounds are designed to aid in the prevention and treatment of amyloid-β related diseases, including Alzheimer's disease. The formula for these compounds is represented as RRX—CR—CH—CH—SOH. Additionally, he has created glucosamine derivatives aimed at preventing or treating joint disorders. These compounds are formulated to address conditions such as arthritis and osteoporosis, showcasing Ai's commitment to improving health outcomes.

Career Highlights

Jinchao Ai is currently employed at Risen (Suzhou) Pharma Tech Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work has not only advanced the field of pharmaceutical chemistry but has also contributed to the betterment of patient care through his inventions.

Collaborations

Ai collaborates with talented individuals in his field, including coworkers Jiasheng Lu and Jiamin Gu. These partnerships enhance the research and development process, leading to more effective and innovative solutions in the pharmaceutical industry.

Conclusion

Jinchao Ai stands out as a key figure in pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions through patents and collaborations reflect his dedication to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…